fruquintinib

Five years after Shire deal, Takeda looks to reap rewards of latest reinvention
BioPharma Dive
Fri, 01/19/24 - 11:12 am
Takeda
M&A
Shire
fruquintinib
Exkivity
Takeda’s Fruzaqla (Fruquintinib) Gets FDA Nod for Metastatic Colorectal Cancer
Xtalks
Thu, 12/21/23 - 09:42 am
Takeda
FDA
colorectal cancer
fruquintinib
Fruzaqla
Takeda Wins FDA Approval for Fruquintinib in Certain Colorectal Cancer Patients
BioSpace
Thu, 11/9/23 - 09:48 am
Takeda
fruquintinib
FDA
colorectal cancer
FDA grants priority review for Takeda and HUTCHMED’s fruquintinib NDA
Pharmaceutical Technology
Fri, 05/26/23 - 11:31 am
Takeda
Hutchmed
FDA
fruquintinib
colorectal cancer
Takeda focuses on ‘diverse’ pipeline prospects on heels of two acquisitions
Endpoints
Mon, 02/6/23 - 10:55 am
Takeda
Nimbus Therapeutics
Hutchmed
colorectal cancer
psoriasis
fruquintinib
The world's twelfth VEGF drug will be sold by Takeda
EP Vantage
Mon, 01/23/23 - 10:43 am
Takeda
Hutchmed
VEGF
fruquintinib
Hutchmed reports positive data from gastric cancer therapy trial
Clinical Trials Arena
Mon, 11/14/22 - 07:09 pm
Hutchmed
fruquintinib
clinical trials
gastric cancer
Boost for "made in China" medicine as Chi-Med wins key approval
Yahoo/Reuters
Wed, 09/5/18 - 09:08 am
China
Chi-Med
Eli Lilly
fruquintinib
colorectal cancer
Billionaire-backed Chi-Med declares PhIII success for pioneering cancer drug in China, seeking quick OK
Endpoints
Sat, 03/4/17 - 12:32 pm
Chi-Med
fruquintinib
oncology
cancer
China
Chi-Med's fruquintinib meets colorectal cancer PhII primary endpoint
Fierce Biotech
Tue, 03/31/15 - 04:07 pm
Chi-Med
fruquintinib
colorectal cancer